A breakthrough technology called “machine perfusion” is leading to increased viability of organs for liver transplants, according to the UC Health transplant team. This innovation has allowed the team to set a new record in 2023 for the number of people saved with solid organ transplants. Machine perfusion involves connecting the donated liver to a perfusion device, which pumps medication through the organ to maintain its condition and regulate it. The portable nature of the machine allows the organ to remain viable for extended periods, such as during transportation to a distant hospital.
Dr. Shimul Shah, the director of the solid organ transplant program at UC Health, states that this technology has contributed to the remarkable growth of the liver transplant program, with a 25% increase from the previous year. The most common conditions requiring a liver transplant are hepatitis and fatty or alcoholic liver disease, although an increasing number of liver transplants are being performed for cancer patients. The use of machine perfusion has significantly improved patient outcomes and reduced waiting times, with the median waiting time now being 15 days compared to the national average of close to a year. The UC Health transplant team emphasizes the importance of organ donors and encourages individuals to sign up to be donors and share their wishes with their families.
